Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
LINC00460 contributes to colorectal cancer cell invasion
Weiguo Ren; Xuexiu Zhang; Qiang Li; Chibin PuShow moreShow less
1. Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 2. Department of Oncology, Shenzhen Hospital, Southern Medical University, Zhengzhou, China; 3. Department of Gastroenterology, Zhongda Hospital, Southeast University, Nanjing, ChinaShow moreShow less
Application of blood purification technology in severe fever with thrombocytopenia syndrome
Hongxia Gao; Baoyin Wang; Hui Yao; Wenjie Zhang; HaiFeng TengShow moreShow less
1. Shandong UniversityShow moreShow less
CDCA7 serves as a novel prognostic marker in human hepatocellular carcinoma
Yuan Tian; Wenwen Han; Long Fu; Kaiji Lv; Shugeng WuShow moreShow less
1. Department of General Surgery, Ningbo Medical Center Lihuili Hospital, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, China; 2. Emergency Department, Ningbo Medical Center Lihuili Hospital, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, ChinaShow moreShow less
Effect of interventional embolization based on absolute ethanol for peripheral arteriovenous malformations
Yanlin Wang; Dakan Liu; Li Xiao; Song Zuo; Tengfei Ren; Changxian Dong; Tianxiao LiShow moreShow less
1. Department of Hemangioma and Vascular Malformation, Zhengzhou University People’s Hospital; Henan Provincial People’s Hospital, Zhengzhou, China; 2. Department of Cerebrovascular Disease, Zhengzhou University People’s Hospital, Henan Provincial People's Hospital, Zhengzhou, China; 3. Henan Provincial NeuroInterventional Engineering Research Center, Henan International Joint Laboratory of Cerebrovascular Disease, and Henan Engineering Research Center of Cerebrovascular Intervention Innovation, Zhengzhou, ChinaShow moreShow less
Effect and imaging analysis of cetuximab combined with radiotherapy in patients with rectal carcinoma
Shuai Zhang; Liangliang Liu; Shuguang Li; Xin SunShow moreShow less
1. Gastrointestinal Cancer Surgery, The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei, China; 2. Department of Pharmacy, Hebei North University, Zhangjiakou, Hebei, China; 3. Department of Imaging, The Fourth People’s Hospital of Jinan, Jinan, Shandong, ChinaShow moreShow less
A Prospective and Randomized Control Study on Effects of Thymalfasin for Injection on Perioperative Immune Function and Long-term Prognosis of Patients with Colorectal Cancer
Wenbo Niu; Zhiying Li; Zhihan Li; Xuhua Hu; Xiaoran Wang; Yuanyi Ding; Chenhui Li; Bin YuShow moreShow less
1. Surgery II, The Fourth Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, China; 2. Cadre ward, The 980th Hospital of the joint logistics support force of the PLA, Shijiazhuang City, Hebei Province, ChinaShow moreShow less
FAQ
How long does Biotechnology and Genetic Engineering Reviews take to review a manuscript?
The publisher marks this journal as ceased in 2024. This page preserves its historical papers and review records. The review times below describe this journal’s historical papers. As of 2026-11-19, CrushSCI has 10 complete review records for Biotechnology and Genetic Engineering Reviews. The fastest paper went from submission to acceptance in 34 days (CDCA7 serves as a novel prognostic marker in human hepatocellular carcinoma, received 2023-04-11, accepted 2023-05-15); the slowest took 91 days. The average is 68.3 days and the median is 75 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
